32.53 USD
▲+0.16+1.53%
盘后 31.93 -0.34%
2026-08-03
市值
$1.93B
市盈率
—
EPS
-2.18
股息率
—
52 周区间
9.96 – 40.65
成交量
396.45K
Beta
0.76
目标价
51.97
52W 低 9.9652W 高 40.65
价格走势
公司简介
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumor...